Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Plunged Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) fell 12% on Wednesday after a court ruling placed a portion of the biotech's blockbuster COVID-19 vaccine proceeds at risk.

A U.S. Court of Appeals for the Federal Circuit panel affirmed a previous ruling by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board. The decision blocked Moderna's attempts to invalidate two of Arbutus Biopharma's (NASDAQ: ABUS) patents on its lipid nanoparticle (LNP) drug-delivery technology.

Moderna uses LNP to deliver its messenger RNA (mRNA) COVID-19 vaccine safely and effectively into patients.

Source Fool.com

Like: 0

MRNA

Share